Subscribe
sjo-
Sjo / iStockphoto.com
2 May 2018Europe

EpiPen patent revoked in Europe

The European Patent Office (EPO) has revoked a patent covering Mylan’s EpiPen (epinephrine) injector after finding that patent amendments contravened the European Patent Convention (EPC).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
EPO gears up to hear EpiPen patent opposition
27 February 2018   The European Patent Office will hear an opposition against a patent covering Mylan’s EpiPen at the end of March.
Americas
FDA grants Teva approval for first EpiPen generic
17 August 2018   The US Food and Drug Administration yesterday granted Teva approval for the first generic version of EpiPen, an autoinjector pen used for the emergency treatment of allergic reactions.
Americas
Judge approves Pfizer’s $345m EpiPen settlement
18 November 2021   EpiPen buyers have secured final approval of a $345 million settlement with Pfizer in a consumer antitrust suit.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

More on this story

Americas
Judge approves Pfizer’s $345m EpiPen settlement
18 November 2021   EpiPen buyers have secured final approval of a $345 million settlement with Pfizer in a consumer antitrust suit.
Big Pharma
EPO gears up to hear EpiPen patent opposition
27 February 2018   The European Patent Office will hear an opposition against a patent covering Mylan’s EpiPen at the end of March.
Americas
FDA grants Teva approval for first EpiPen generic
17 August 2018   The US Food and Drug Administration yesterday granted Teva approval for the first generic version of EpiPen, an autoinjector pen used for the emergency treatment of allergic reactions.

More on this story

Americas
Judge approves Pfizer’s $345m EpiPen settlement
18 November 2021   EpiPen buyers have secured final approval of a $345 million settlement with Pfizer in a consumer antitrust suit.
Big Pharma
EPO gears up to hear EpiPen patent opposition
27 February 2018   The European Patent Office will hear an opposition against a patent covering Mylan’s EpiPen at the end of March.
Americas
FDA grants Teva approval for first EpiPen generic
17 August 2018   The US Food and Drug Administration yesterday granted Teva approval for the first generic version of EpiPen, an autoinjector pen used for the emergency treatment of allergic reactions.

More features

Novartis shields eye-drop patent at European Patent Office
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York
UPC deals further blow to Dexcom in glucose monitor dispute with Abbott
‘A marathon and a sprint at the same time’: How we won $452m damages
Judge denies Intellia bid to throw out suit over $100m Regeneron pact